Showing posts with label alzheimer's and insulin. Show all posts
Showing posts with label alzheimer's and insulin. Show all posts

Friday, May 10, 2013

Diet may improve Alzheimer's

Caregivers and healthcare professionals, here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,

Your residents will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care professionals to get an easyceu or two

Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition

News Fix
 
A study suggests that a high fat, low carbohydrate diet can help improve Alzheimer’s disease in mice.
It’s been previously suggested that a high fat diet may predispose the brain to Alzheimer’s disease, perhaps by clogging up the arteries. Researchers in Colorado seem to be suggesting the opposite – at least from animal studies.

They have been looking at a group of mice with the equivalent of Alzheimer’s disease. Giving the animals a diet that is high in fat, low in carbohydrate, reduces the amount of beta-amyloid, the brain protein deposits which are the hallmarks of Alzheimer’s disease. The researchers explain their results suggesting that insulin and insulin-related growth factor may be involved. In this kind of diet, insulin seems to be able to break up the amyloid deposits. Other studies have looked at fat in the presence of high carbohydrate. When the carbohydrates are reduced, insulin may behave in a more positive way.
 

Tuesday, May 22, 2012

Alzheimer's plan and drug trials


Here is a great dementia resource for caregivers and healthcare professionals,


You will love the Amazon Kindle Fire


Here is information on being the best caregiver you can be


Here is a way for nurses administrators, social workers and other health care professionals to get an easyceu or two


Follow Alzheimers1 on twitter

Medpage Today

Friday, April 20, 2012

Diabetics are fifty percent more likely to develop dementia

Here is a great dementia resource for caregivers and healthcare professionals,

You will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care professionals to get an easyceu or two

Follow Alzheimers1 on twitter

Philly.com

Several large studies have shown that people with diabetes are at especially high risk for Alzheimer's disease.

Steven Arnold, director of the University of Pennsylvania's Memory Center, said diabetics are 50 to 100 percent more likely to get the fatal, memory-destroying disease.

This has made researchers increasingly interested in the role that insulin, the hormone that's out of whack in diabetes, might play in Alzheimer's.
In the brain, Arnold said, insulin is important for cell growth and releasing neurotransmitters that allow cells to communicate. It enhances learning and memory.

Arnold is the senior author of a new study in the Journal of Clinical Investigation that looked at the brains of people with Alzheimer's disease and mild cognitive impairment, often a precursor to dementia. He found insulin resistance in their brains, even though the people did not have diabetes. Arnold said the chemical differences between those who did and did not have memory problems were striking. "I've never seen a difference this large," he said.

When cells are insulin resistant, insulin is present but the cells don't respond as much as they normally would. Insulin resistance is the hallmark of Type 2 diabetes, the kind that 90 percent of American diabetics have. Untreated, it leads to high blood sugar.

Arnold's team studied brain samples taken from people who had died. Even in dead cells, several steps of chemical reactions could be seen. The study found "tremendous abnormalities pretty much all the way down the line" in people with Alzheimer's.

There's no easy way to test brain insulin resistance in the living. Arnold said it's likely that people with diabetes have brain insulin resistance, but others could have it, too.

Many diabetes drugs are designed to lower blood sugar, but some act as insulin sensitizers. Arnold is now seeking funding to test whether one such drug, metformin, can help people with dementia or mild cognitive impairment.

- Stacey Burling

Saturday, September 17, 2011

Intranasal insulin treatment for Alzheimer's disease

Here is a great dementia resource for caregivers and healthcare professinals,

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care professionals to get an easyceu or two

Alzheimer's Association

Currently, there is no cure for Alzheimer's disease. But drug and non-drug treatments may help with both cognitive and behavioral symptoms. Researchers are looking for new treatments to alter the course of the disease and improve the quality of life for people with dementia.

In an article published September 13, 2011, in the Archives of Neurology, results from a small, short-term treatment trial (four months) of intranasal insulin in Alzheimer's disease and mild cognitive impairment (MCI) showed statistically significant benefits on certain tests of memory and functioning, but no changes on some others. In those people who showed benefits on memory tests, the researchers also measured changes in chemicals in participants' spinal fluid that may indicate a beneficial effect of the treatment on Alzheimer's.

It is important to note that, quite often, preliminary studies like this generate positive results but fail to show long-term benefit in larger trials. That said, these findings are very encouraging, and further research — longer trials with larger numbers of participants — of intranasal insulin as a therapy for Alzheimer's and MCI is warranted.

We urgently need earlier detection and better treatments for Alzheimer's, which is a devastating, heartbreaking and fatal disease, and a growing epidemic. This requires a greater commitment to research — increasing funding for Alzheimer's research and recruiting more volunteers for Alzheimer's clinical trials.



























































































































































Researchers selected 104 men and women for the study. All had either mild to moderate Alzheimer's or mild cognitive impairment, a condition that increases the risk of developing Alzheimer's, especially when memory is affected. The participants were divided into three groups. Using a nasal spray, each group received twice-daily doses of either lower or higher doses of insulin or a placebo.

The study found that men and women who used the lower dose of insulin nasal spray tended to score better on memory tests than those who used the placebo. No improvement was seen in those receiving the higher insulin dose. Both groups receiving insulin preserved their level of daily functioning, according to reports from their caregivers, while participants in the placebo group showed an overall decline in function. Few side effects occurred among those treated with the insulin spray, other than occasional light-headedness and dizziness or stuffy nose.

Related
•Minor ailments linked to Alzheimer's. Read
•Can you walk away from dementia? Read
•Eating berries may protect against dementia, Alzheimer's. Read
•Do drugs for treating early-stage Alzheimer's work? Read

The brain needs insulin

Over the past 10 years scientists have come to learn that insulin plays an important role in the brain, says clinical neuroscientist Suzanne Craft, of the Veterans Affairs Puget Sound Health Care System and the University of Washington School of Medicine. It helps the brain form memories, allows brain cells to communicate with one another and manages levels of brain chemicals.

All cells, including those that make up the brain, use glucose for energy. The hormone insulin makes it possible for glucose, aka blood sugar, to enter cells, enabling them to work properly. With age, however, many people develop a problem called insulin resistance, a condition in which the body and the brain do not use insulin effectively.

If glucose cannot enter brain cells, the cells won't carry out their tasks related to memory and thinking. "This sets the stage for problems in brain function that may develop into conditions like Alzheimer's disease," says Craft, lead author of the study. She and her colleagues set out to determine whether providing insulin directly to the brain could improve the cell's ability to use insulin.

Wednesday, February 4, 2009

Insulin is a possible new treatment for Alzheimer's

Eurekalert

EVANSTON, Ill. --- A Northwestern University-led research team reports that insulin, by shielding memory-forming synapses from harm, may slow or prevent the damage and memory loss caused by toxic proteins in Alzheimer's disease.

The findings, which provide additional new evidence that Alzheimer's could be due to a novel third form of diabetes, will be published online the week of Feb. 2 by the Proceedings of the National Academy of Sciences (PNAS).

In a study of neurons taken from the hippocampus, one of the brain's crucial memory centers, the scientists treated cells with insulin and the insulin-sensitizing drug rosiglitazone, which has been used to treat type 2 diabetes. (Isolated hippocampal cells are used by scientists to study memory chemistry; the cells are susceptible to damage caused by ADDLs, toxic proteins that build up in persons with Alzheimer's disease.)

The researchers discovered that...read the whole story

For dementia information, click here

For Alzheimer's and dementia activities, click here
Blog Flux Directory
alzheimersideas - whereIstand.com

Fitness is important in dementia prevention. Click below for more info